Tags: sciencehealththe conversationinfectious diseasevaccines
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Theresa Gaffney STAT News Audio producer, health reporter. Boston | A STAT Investigation: Pain, loss, and coercive care - 4 days ago | |
| 2 | Nicoletta Lanese Live Science Science journalist. New York, USA | ||
| 3 | Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Mpox Cases in Congo May Be Stabilizing - 10 days ago | |
| 4 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Pharma takes aim at a wily foe — the Epstein-Barr virus - 11 days ago | |
| 5 | MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | ||
| 6 | Katherine Kahn MedPage Today Physician-Scientist. Studies Long Covid. United States | CDC Addresses Rebound of Mycoplasma Pneumonia in Kids - 9 months ago | |
| 7 | Helen Branswell STAT News Frontiers of health & medicine reporting. | Moderna reports encouraging results on its mpox vaccine, as outbreaks in Africa spread - 2 months ago Why a leading bird flu expert isn’t convinced that the risk H5N1 poses to people has declined - 7 months ago 3 issues to watch in global health in 2024 - 11 months ago | |
| 8 | Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom | Daily briefing: Raising the alarm about the monkeypox virus - 3 months ago Daily briefing: What’s causing a pneumonia surge in China - 12 months ago | |
| 9 | Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. | ||
| 10 | Jason Mast STAT News Writing about science, medicine. | Antiviral used for mpox no better than placebo, NIH says - 3 months ago |